These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22912729)

  • 1. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
    Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
    PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.
    Mehta AJ; Thun GA; Imboden M; Ferrarotti I; Keidel D; Künzli N; Kromhout H; Miedinger D; Phuleria H; Rochat T; Russi EW; Schindler C; Schwartz J; Vermeulen R; Luisetti M; Probst-Hensch N;
    Occup Environ Med; 2014 Apr; 71(4):234-40. PubMed ID: 24213563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
    Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
    Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Rare
    Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
    Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.
    North TL; Ben-Shlomo Y; Cooper C; Deary IJ; Gallacher J; Kivimaki M; Kumari M; Martin RM; Pattie A; Sayer AA; Starr JM; Wong A; Kuh D; Rodriguez S; Day IN
    J Med Genet; 2016 Apr; 53(4):280-8. PubMed ID: 26831755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
    Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
    Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.
    Zorzetto M; Russi E; Senn O; Imboden M; Ferrarotti I; Tinelli C; Campo I; Ottaviani S; Scabini R; von Eckardstein A; Berger W; Brändli O; Rochat T; Luisetti M; Probst-Hensch N;
    Clin Chem; 2008 Aug; 54(8):1331-8. PubMed ID: 18515255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
    Piitulainen E; Carlson J; Ohlsson K; Sveger T
    Chest; 2005 Oct; 128(4):2076-81. PubMed ID: 16236857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels and genotype distribution of α1-antitrypsin in the general population.
    Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
    Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated spirometric decline in New York City firefighters with α₁-antitrypsin deficiency.
    Banauch GI; Brantly M; Izbicki G; Hall C; Shanske A; Chavko R; Santhyadka G; Christodoulou V; Weiden MD; Prezant DJ
    Chest; 2010 Nov; 138(5):1116-24. PubMed ID: 20634282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
    Lechowicz U; Martinez-Delgado B; Liu B; Wrenger S; Rozy A; Zdral A; DeLuca DS; Welte T; Janciauskiene S; Chorostowska-Wynimko J
    Clin Biochem; 2024 Apr; 126():110736. PubMed ID: 38428450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
    Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
    Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype in
    Ponce-Gallegos MA; Pérez-Rubio G; García-Carmona A; García-Gómez J; Hernández-Zenteno R; Ramírez-Venegas A; Falfán-Valencia R
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population.
    Silva GE; Sherrill DL; Guerra S; Barbee RA
    Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype.
    Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL
    Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.